Marijuana Moment: Veteran Access To Psychedelics Requires Balance Of Speed And Caution, Says Panel With VA And Former CDC Officials
Experts and advocates—including a Department of Veterans Affairs (VA) official and a former director of the Centers for Disease Control and Prevention (CDC)—recently convened for a Harvard University panel to discuss efforts to expand veteran access to psychedelic-assisted therapy.
Pharmacy Times: Psychedelic-Assisted Therapy Is Life-Changing for Veterans With PTSD, Yet Access to These Therapies Remain Outside the United States
Pharmacy Times interviewed Marcus Capone and Amber Capone, the co-founders of Veterans Exploring Treatment Solutions (VETS), on the current opportunities available for US veterans to seek psychedelic-assisted therapies for post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBIs).
- 10.10.2023
- Updates
VETS Joins Coalition to Heal Invisible Wounds
Veterans, service members and their caregivers need better solutions for the invisible wounds of war.
Bloomberg: Toms Shoes Founder Talks Funding Plan For Psychedelics Movement
Blake Mycoskie, the founder of Toms Shoes, announced earlier this year that he’d give $100 million to support research into the medical and mental health potential of psychedelic drugs.
KY Attorney General Daniel Cameron: Kentucky Opioid Abatement Advisory Commission Public Hearing
On Friday, September 15, 2023, VETS co-founders Marcus and Amber Capone testified for the Kentucky Opioid Abatement Advisory Commission in support of research into ibogaine as a treatment for opioid use disorder.